 |
 |
 |
Search Stock:
Piramal Pharma Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Piramal Pharma (PPLPHARMA (Bse Code: 543635)) Key Ratios
P/E
Company-92.63
Sector7.43
A Price-to-Earnings of -92.63 means investors pay -92.63 units per 1 unit of earnings. This is higher than the sector average of 7.43.
P/B
Company3.56
Sector4.39
A P/B ratio of 3.56 shows market value relative to book value. This is lower than the sector average of 4.39.
ROA
Company-1.75%
Sector-17.84%
Return on Assets shows a -1.75% profit per unit of asset. This is lower than the sector average of -17.84%.
ROE
Company-3.58%
Sector-2.58%
Return on Equity creates -3.58% profit per unit of equity. This is higher than the sector average of -2.58%.
ROCE
Company2.58%
Sector6.43%
ROCE indicates 2.58% operating earnings per unit of capital. This is lower than the sector average of 6.43%.
Quick Ratio
Company0.87
Sector6.69
The Quick Ratio is 0.87 compared to sector average 6.69.
EV/EBITDA
Company30.18
Sector14.88
EV/EBITDA of 30.18 means value is 30.18 times core earnings. This is higher than the sector average of 14.88.
Piramal Pharma Share Price Analysis Local DB
Piramal Pharma share price is ₹213.78, day high (share price) is ₹217.82, day low (share price) is ₹211.36 and volume is 3,102,064. 52 Week high share price for Piramal Pharma is ₹220.36 on 21 Aug 2026 and 52 week low share price for Piramal Pharma is ₹132.30 on 23 Mar 2026. Price data as of: 02 Sep, 2026 3:31 PM.
According to latest price data (as of 02 Sep, 2026 3:31 PM) for Piramal Pharma share, 14 day period RSI (Relative Strength Index) is 59.5, 50 DMA (50 Displaced Moving Average) is 193.00 and 200 DMA (200 Displaced Moving Average) is 171.77.
▲
₹213.78
0.58 (0.27%)
As of 02 Sep, 2026
Open
₹212.84
Day High - Low
₹217.82 - ₹211.36
Volume
3,102,064
52 Weeks High
₹220.36
on 21 Aug 2026
52 Weeks Low
₹132.30
on 23 Mar 2026
RSI (14)
59.5
50 DMA
193.00
200 DMA
171.77
Loading...
Piramal Pharma (PPLPHARMA) Technical Analysis
₹213.78
+0.58
02 Sep, 2026
Piramal Pharma Technical Data and Analysis available in multiple timeframes.
Piramal Pharma Oscillators Analysis
On the Day timeframe, the outlook for PPLPHARMA is: The long-term trend is Positive (Price vs 200 SMA) and RSI (14) is: 59.4.
Piramal Pharma Price Action
Piramal Pharma Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 59.45 |
| Stoch %K (14, 3, 3) | 67.59 |
| CCI (20) | 56.96 |
| ADX (14) | 35.12 |
| Awesome Osc | 12.41 |
| Momentum (10) | 4.14 |
| MACD (12, 26, 9) | 5.80 |
| MACD Signal | 6.77 |
| Stoch RSI (14) | 16.68 |
| Williams %R (14) | -32.48 |
| Bull/Bear Power | 4.96 |
| Ultimate Osc | 48.33 |
| MFI (14) | 57.61 |
| ROC (21) | 5.57 |
| ROC (125) | 36.92 |
| ATR (14) | 7.14 |
Piramal Pharma Moving Averages
PPLPHARMA is trading above 13 out of 14 SMAs.
213.78
CURRENT PRICE
Bullish Moving Averages
13
Bearish Moving Averages
1
5 SMA215.00
8 SMA213.15
9 SMA213.20
10 SMA213.55
12 SMA212.97
20 SMA211.78
21 SMA211.54
26 SMA208.93
30 SMA205.99
34 SMA202.94
50 SMA193.00
100 SMA179.49
150 SMA170.32
200 SMA171.77
| Ichimoku Base | 206.48 | Above Base |
| VWMA (20) | 211.59 | Above VWMA |
| HMA (9) | 215.49 | Below HMA |
Piramal Pharma Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- RSI at 59.45 reflects mild positive momentum.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Piramal Pharma Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 221.67 | 221.27 | 214.75 | 218.89 |
| Resistance 2 | 218.89 | 218.70 | 214.23 | 216.75 |
| Resistance 1 | 216.05 | 215.65 | 213.72 | 215.42 |
| Pivot Point | 213.27 | 213.08 | 213.20 | 213.27 |
| Support 1 | 210.43 | 210.03 | 212.68 | 211.13 |
| Support 2 | 207.65 | 207.46 | 212.17 | 209.80 |
| Support 3 | 204.81 | 204.41 | 211.65 | 207.65 |
Records:
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
Records:
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Piramal Pharma - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 34.80% | 34.86% | 34.86% | 34.86% |
| FII | 12.52% | 30.18% | 29.66% | 30.27% |
| DII (Other) | 1.39% | 1.49% | 1.66% | 1.78% |
| Retail & Others | 38.11% | 19.35% | 19.80% | 19.98% |
| Mutual Funds | 13.18% | 14.12% | 14.03% | 13.11% |
Piramal Pharma - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 9,082.38 -2.19% | -176.06 -142.46% | -325.94 -457.66% |
| Mar 2025 | 9,285.99 +11.26% | 414.64 +131.27% | 91.13 +411.39% |
| Mar 2024 | 8,346.55 +14.23% | 179.29 +249.22% | 17.82 +109.56% |
| Mar 2023 | 7,306.66 | -120.15 | -186.46 |
No corporate actions data available.
Piramal Pharma Share Price and Volume Historical Data
Synchronizing MarketBandhu Database...